Maxigen Biotech Inc (1783) — Net Asset Quality Index
Maxigen Biotech Inc (1783) has a Net Asset Quality Index of 81.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.99 Billion minus total liabilities of NT$364.27 Million yields net assets of NT$1.63 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 1783 financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Maxigen Biotech Inc Net Asset Quality Index Over Time (2009–2025)
This chart shows how Maxigen Biotech Inc's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of March 2026, the index stands at 81.7%, representing net assets of NT$1.63 Billion against total assets of NT$1.99 Billion TWD. See Maxigen Biotech Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Maxigen Biotech Inc (2009–2025)
The table below presents the year-by-year Net Asset Quality Index for Maxigen Biotech Inc from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 1783 market cap overview.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.2% | NT$1.54 Billion | NT$1.89 Billion | NT$355.54 Million | ▼ -5.7 pp |
| 2024 | 86.9% | NT$1.38 Billion | NT$1.58 Billion | NT$207.36 Million | ▼ -4.3 pp |
| 2023 | 91.2% | NT$1.36 Billion | NT$1.49 Billion | NT$131.88 Million | ▲ +1.7 pp |
| 2022 | 89.5% | NT$1.30 Billion | NT$1.45 Billion | NT$152.07 Million | ▼ -0.7 pp |
| 2021 | 90.2% | NT$1.14 Billion | NT$1.27 Billion | NT$123.47 Million | ▲ +0.3 pp |
| 2020 | 89.9% | NT$860.23 Million | NT$956.47 Million | NT$96.24 Million | ▲ +18.1 pp |
| 2019 | 71.8% | NT$851.32 Million | NT$1.19 Billion | NT$334.17 Million | ▼ -2.4 pp |
| 2018 | 74.2% | NT$842.98 Million | NT$1.14 Billion | NT$292.48 Million | ▲ +2.1 pp |
| 2017 | 72.1% | NT$796.25 Million | NT$1.10 Billion | NT$307.73 Million | ▲ +0.9 pp |
| 2016 | 71.2% | NT$781.38 Million | NT$1.10 Billion | NT$316.04 Million | ▲ +0.2 pp |
| 2015 | 71.0% | NT$829.86 Million | NT$1.17 Billion | NT$338.38 Million | ▼ -15.5 pp |
| 2014 | 86.5% | NT$877.01 Million | NT$1.01 Billion | NT$136.65 Million | ▼ -1.1 pp |
| 2013 | 87.6% | NT$888.39 Million | NT$1.01 Billion | NT$126.04 Million | ▲ +11.3 pp |
| 2012 | 76.3% | NT$385.66 Million | NT$505.76 Million | NT$120.10 Million | ▲ +0.4 pp |
| 2011 | 75.9% | NT$369.25 Million | NT$486.65 Million | NT$117.40 Million | ▼ -16.1 pp |
| 2010 | 92.0% | NT$395.39 Million | NT$429.76 Million | NT$34.37 Million | ▲ +0.9 pp |
| 2009 | 91.1% | NT$313.03 Million | NT$343.55 Million | NT$30.51 Million | — |